Furthermore, Wang X and colleagues leveraged microsatellite stable CRC humanized mouse models and co-culture systems of colorectal cancer organoids with CD8+ T cells to demonstrate that Fusobacterium nucleatum, a CRC-associated pathogen, enhances the sensitivity of microsatellite stable CRC to immunotherapy, offering novel directions for clinical treatment [40]. This evidence concerns the gene CD8A and colorectal carcinoma.